News

NCCN Annual Conference: Managing Basal Cell and Squamous Cell Skin Cancers by Risk Status

AACR 2024: Rural Residency and Melanoma Mortality

NCCN Annual Conference: Update on Managing Cutaneous Melanoma

Relationship Between Somatic Mutations and Risk of Skin Cancer Under Investigation

Trends in Melanoma Surveillance and Their Clinical Implications

Some Antihypertensive Drugs May Increase Susceptibility to Skin Cancer, Study Finds

AACR 2024: Biomarker Offers Clues to Melanoma Resistance to Immune Checkpoint Blockade

AACR 2024: Novel Biomarker and Potential Therapeutic Target Identified in Cutaneous SCC

Detecting and Preventing Skin Cancer for Individuals With Intellectual Disabilities

Anti–PD-L1 Refractory Melanoma: Combining Tyrosine Kinase and PD-1 Inhibitors

Noncoding Genes and Therapeutic Research in Basal Cell Carcinoma

SSO 2024: Do Surgical Characteristics Impact TIL Therapy Outcomes in Melanoma?

AAD 2024: Frankincense Application May Impact Melanoma Diagnosis

Targeting Cutaneous and Rare Melanoma Subtypes With Anti-TYRP1 CAR T-Cell Therapy

AAD 2024: Case Study Opens Debate About Surveillance After Merkel Cell Carcinoma

SSO 2024: Understanding Recurrence of Cutaneous Melanoma During and After Adjuvant Immunotherapy

AAD 2024: Keynote Speaker William Shatner Shares His Journey With Stage IV Melanoma

AAD 2024: ‘Sustained’ Activity Reported With Sonidegib in Locally Advanced Basal Cell Carcinoma

Novel T-Cell Therapy After PD-1 Blockade Under Study in Merkel Cell Carcinoma

AAD 2024: Melanoma Subtype–Specific Outcomes in Black vs White Patients

AAD 2024: Factors Associated With Skin Graft Receipt and Hospital Charges in Basal Cell Carcinoma

Combined-Modality Approach to Treatment of Basal Cell Carcinoma of the Head and Neck

Advanced Non-Melanoma Skin Cancer: Avoiding Surgery With Upfront Systemic and Radiation Therapies

BRAF V600–Mutated Melanoma: Long-Term Outcomes With Immunotherapy

Cannabis Extract PHEC-66: Potential Adjuvant Therapy for Malignant Melanoma?

Merkel Cell Carcinoma: Timing of Surgery and Survival Outcomes

FDA Grants Accelerated Approval to Cellular Therapy for Unresectable or Metastatic Melanoma

KEYNOTE-942: Neoantigen Therapy Plus Pembrolizumab in Resected Melanoma

Kidney Transplant Recipients: Immunotherapy Strategy for Cutaneous Squamous Cell Carcinoma

AI-Powered Medical Device to Detect Common Skin Cancers Granted FDA Clearance

Use of Cemiplimab-rwlc After Hedgehog Inhibitor Therapy in Locally Advanced Basal Cell Carcinoma

Radiotherapy for Older Adults With Cutaneous Squamous Cell Carcinoma of the Head/Neck

Cutaneous Head and Neck Squamous Cell Carcinoma: Impact of Socioeconomic Factors on Outcomes

Are PD-L1 Expression and Polyomavirus Linked to Survival Among Patients With Merkel Cell Carcinoma?

Surgical Treatment With Three Skin Flaps of Basosquamous Carcinoma: Case Report

Cryosurgery Plus 5-FU vs Monotherapy in Non-Melanoma Skin Cancer: Canadian Study Findings

Squamous Cell Carcinoma of the Eyelid: Multidisciplinary Team Required

Predicting Immunotherapy Responsiveness Based on T-Cell Expression in Patients With Advanced Skin Cancer

Genomic Analysis of Cutaneous Squamous Cell Cancer: What Researchers Have Learned

Mortality and Non-Melanoma Skin Cancer: Surprising Global Trends